Quintrio
Home

Stock overview

NuCana plc American Depositary Share

NCNA

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.

Last trade $0.7883
Day change -$0.0748 (-8.67%)
Day range $0.778 – $0.937
Volume 36,938
Market cap $4M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for NCNA.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for NCNA, quarterly periods
Line itemQ3 FY2024 Sep 30, 2024
Revenue$0
Cost of revenue$0
Gross profit$0
Selling, general and administrative$6.9M
Research and development$26.25M
Total operating expenses$33.15M
Operating income-$33.15M
Interest expense-$1K
Income before taxes-$30.48M
Income taxes$0
Net income-$30.48M
Net income attributable to common shareholders-$30.48M
EBITDA-$31.56M
Basic earnings per share-$5.44
Diluted earnings per share-$5.44

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

NuCana Appoints Theresa Bruce as Chief Operating Officer

NuCana plc announced the appointment of Theresa Bruce as Chief Operating Officer effective January 1, 2026. Bruce brings over 25 years of experience in oncology R&D and clinical operations. The appointment comes as NuCana plans to advance its pipeline with anticipated data readouts in 2026 for NUC-7738 and further characterization of NUC-3373, with cash runway extending into 2029.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Aug 11, 20251-for-200reverse split
Apr 16, 20241-for-25reverse split